We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+8.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$80B
AUM Growth
+$5.37B
Cap. Flow
-$213M
Cap. Flow %
-0.27%
Top 10 Hldgs %
23.95%
Holding
3,773
New
259
Increased
1,520
Reduced
1,671
Closed
192

Sector Composition

Rank Sector Weight
1 Technology 14.33%
2 Healthcare 8.9%
3 Financials 7.71%
4 Consumer Discretionary 6.92%
5 Industrials 6.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTR
2951
Virtus Total Return Fund
ZTR
$338M
$288K ﹤0.01%
36,731
-1,544
-4% -$12.5K
EIG icon
2952
Employers Holdings
EIG
$871M
$287K ﹤0.01%
+9,474
New +$300K
FCG icon
2953
First Trust Natural Gas ETF
FCG
$639M
$286K ﹤0.01%
47,003
-31,598
-40% -$231K
FBMS
2954
DELISTED
The First Bancshares, Inc.
FBMS
$286K ﹤0.01%
13,650
+13
+0.1% +$275
JTA
2955
DELISTED
Nuveen Tax-Advantaged Total Return Strategy Fund
JTA
$286K ﹤0.01%
35,719
-2,560
-7% -$21.3K
AXSM icon
2956
Axsome Therapeutics
AXSM
$11.2B
$285K ﹤0.01%
4,003
CRUS icon
2957
Cirrus Logic
CRUS
$6.08B
$285K ﹤0.01%
4,227
-476
-10% -$29.8K
PRAA icon
2958
PRA Group
PRAA
$762M
$285K ﹤0.01%
7,143
-14
-0.2% -$582
MDRX
2959
DELISTED
Veradigm Inc. Common Stock
MDRX
$285K ﹤0.01%
35,011
-5,685
-14% -$46.5K
AMPH icon
2960
Amphastar Pharmaceuticals
AMPH
$858M
$284K ﹤0.01%
15,147
+1,470
+11% +$29.6K
BALY icon
2961
Bally's
BALY
$660M
$284K ﹤0.01%
+10,795
New +$251K
GIL icon
2962
Gildan
GIL
$10.6B
$284K ﹤0.01%
14,432
-13,378
-48% -$247K
AE
2963
DELISTED
Adams Resources & Energy Inc
AE
$284K ﹤0.01%
+14,269
New +$316K
BBBY
2964
Bed Bath & Beyond
BBBY
$423M
$282K ﹤0.01%
+4,269
New +$291K
OIA icon
2965
Invesco Municipal Income Opportunities Trust
OIA
$292M
$282K ﹤0.01%
38,609
+128
+0.3% +$943
RFI
2966
Cohen & Steers Total Return Realty Fund
RFI
$309M
$282K ﹤0.01%
23,606
+3,345
+17% +$41.8K
BPFH
2967
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$282K ﹤0.01%
51,000
+2,427
+5% +$14.5K
TT icon
2968
CALL
Trane Technologies
TT
$105B
$281K ﹤0.01%
+40,300
New +$4.53M
CPRI icon
2969
Capri Holdings
CPRI
$1.77B
$280K ﹤0.01%
15,534
-18,445
-54% -$313K
SYBT icon
2970
Stock Yards Bancorp
SYBT
$2.64B
$280K ﹤0.01%
8,234
-2,988
-27% -$119K
ACIO icon
2971
Aptus Collared Investment Opportunity ETF
ACIO
$2.44B
$279K ﹤0.01%
+10,467
New +$276K
APPS icon
2972
Digital Turbine
APPS
$1.53B
$279K ﹤0.01%
+8,531
New +$184K
ILCB icon
2973
iShares Morningstar US Equity ETF
ILCB
$1.33B
$279K ﹤0.01%
5,728
+12
+0.2% +$572
AOK icon
2974
iShares Core Conservative Allocation ETF
AOK
$795M
$278K ﹤0.01%
7,475
-2,840
-28% -$106K
MGRC icon
2975
McGrath RentCorp
MGRC
$2.94B
$277K ﹤0.01%
+4,651
New +$280K

Similar funds

Raymond James & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Raymond James & Associates held 3,773 positions worth $80B, up 7.2% from $74.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2020 filing shows 259 new, 1,520 increased, 1,671 reduced and 192 closed positions. Its largest new stake was Rocket Companies: 405,835 shares worth $8.09M. The largest sale was Apple, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2020 buy was Rocket Companies: 405,835 shares worth $8.09M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2020, an estimated $140M increase.
  • Raymond James & Associates's biggest Q3 2020 reduction was Apple, cutting an estimated $134M.
  • Raymond James & Associates fully exited Invesco Russell 1000 Dynamic Multifactor ETF in Q3 2020, selling an estimated $15.9M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $80B portfolio in Q3 2020.
  • Raymond James & Associates opened 259 new positions and closed 192 in Q3 2020.
  • Raymond James & Associates's portfolio value rose 7.2% quarter-over-quarter to $80B.

Based on Raymond James & Associates's 13F filing for Q3 2020, filed 4 Nov 2020.